These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 32123140)

  • 41. Hemodynamic follow-up after valve-in-valve TAVR for failed aortic bioprosthesis.
    Wilbring M; Kappert U; Haussig S; Winata J; Matschke K; Mangner N; Arzt S; Alexiou K
    J Card Surg; 2022 Dec; 37(12):4654-4661. PubMed ID: 36273424
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Self-Expanding Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Patients at High Risk for Surgery: A Study of Echocardiographic Change and Risk Prediction.
    Little SH; Oh JK; Gillam L; Sengupta PP; Orsinelli DA; Cavalcante JL; Chang JD; Adams DH; Zorn GL; Pollak AW; Abdelmoneim SS; Reardon MJ; Qiao H; Popma JJ
    Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27313280
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluation of structural valve deterioration and bioprosthetic valve failure utilizing the new European consensus definition in patients undergoing TAVI with first-generation devices: Outcomes beyond 5 years from a single center in Turkey.
    Şentürk B; Dursun H; Çöllüoğlu T; Özdamar H; Ekin T; Tanrıverdi Z; Kaya D
    Anatol J Cardiol; 2021 Aug; 25(8):579-587. PubMed ID: 34369886
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hemodynamic comparison of CoreValve and SAPIEN-XT TAVI valves in Japanese patients.
    Shishido K; Yamanaka F; Ochiai T; Yamabe T; Noguchi K; Ota T; Koide Y; Ogino H; Tanaka Y; Saito S
    Heart Vessels; 2019 Oct; 34(10):1674-1683. PubMed ID: 30993441
    [TBL] [Abstract][Full Text] [Related]  

  • 45. First North American experience with the transfemoral ACURATE-neo
    Bagur R; Teefy PJ; Kiaii B; Diamantouros P; Chu MWA
    Catheter Cardiovasc Interv; 2017 Jul; 90(1):130-138. PubMed ID: 27677241
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-Term Outcomes in Patients With New Permanent Pacemaker Implantation Following Transcatheter Aortic Valve Replacement.
    Chamandi C; Barbanti M; Munoz-Garcia A; Latib A; Nombela-Franco L; Gutiérrez-Ibanez E; Veiga-Fernandez G; Cheema AN; Cruz-Gonzalez I; Serra V; Tamburino C; Mangieri A; Colombo A; Jiménez-Quevedo P; Elizaga J; Laughlin G; Lee DH; Garcia Del Blanco B; Rodriguez-Gabella T; Marsal JR; Côté M; Philippon F; Rodés-Cabau J
    JACC Cardiovasc Interv; 2018 Feb; 11(3):301-310. PubMed ID: 29413244
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Midterm Outcomes for Valve-in-Valve Transcatheter Aortic Valve Replacement in the Failed Freestyle Bioprosthesis.
    Wai Sang SL; DeBruine N; Beute T; Heiser J; Berkompas D; Merhi W
    Ann Thorac Surg; 2020 Dec; 110(6):1951-1957. PubMed ID: 32442615
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Self-expanding transcatheter aortic valve implantation for degenerated Mitroflow bioprosthesis: Early outcomes.
    Pascual I; Avanzas P; Hernández-Vaquero D; Díaz R; Del Valle R; Padrón R; Lorca R; León V; Martín M; Alfonso F; Morís C
    Int J Cardiol; 2019 Jul; 287():53-58. PubMed ID: 30772015
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Feasibility of coronary angiography and percutaneous coronary intervention after transcatheter aortic valve replacement using a Medtronic™ self-expandable bioprosthetic valve.
    Htun WW; Grines C; Schreiber T
    Catheter Cardiovasc Interv; 2018 Jun; 91(7):1339-1344. PubMed ID: 28988450
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety and efficacy of a self-expanding versus a balloon-expandable bioprosthesis for transcatheter aortic valve replacement in patients with symptomatic severe aortic stenosis: a randomised non-inferiority trial.
    Lanz J; Kim WK; Walther T; Burgdorf C; Möllmann H; Linke A; Redwood S; Thilo C; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Schymik G; Prendergast B; Husser O; Stortecky S; Heg D; Jüni P; Windecker S; Pilgrim T;
    Lancet; 2019 Nov; 394(10209):1619-1628. PubMed ID: 31570258
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Early Outcomes for Valve-in-valve Transcatheter Aortic Valve Replacement in Degenerative Freestyle Bioprostheses.
    Sang SLW; Beute T; Heiser J; Berkompas D; Fanning J; Merhi W
    Semin Thorac Cardiovasc Surg; 2018 Autumn; 30(3):262-268. PubMed ID: 29158054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Complications after Transfemoral Transcatheter Aortic Valve Replacement with a Balloon-Expandable Prosthesis: The Importance of Preventative Measures and Contingency Planning.
    Chakravarty T; Jilaihawi H; Doctor N; Fontana G; Forrester JS; Cheng W; Makkar R
    Catheter Cardiovasc Interv; 2018 Apr; 91(5):E29-E42. PubMed ID: 23436313
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Computed Tomography-Based Indexed Aortic Annulus Size to Predict Prosthesis-Patient Mismatch.
    Head SJ; Reardon MJ; Deeb GM; Van Mieghem NM; Popma JJ; Gleason TG; Williams MR; Radhakrishnan S; Fremes S; Oh JK; Chang Y; Boulware MJ; Kappetein AP
    Circ Cardiovasc Interv; 2019 Apr; 12(4):e007396. PubMed ID: 30929507
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Commissural Alignment of Bioprosthetic Aortic Valve and Native Aortic Valve Following Surgical and Transcatheter Aortic Valve Replacement and its Impact on Valvular Function and Coronary Filling.
    Fuchs A; Kofoed KF; Yoon SH; Schaffner Y; Bieliauskas G; Thyregod HG; Makkar R; Søndergaard L; De Backer O; Bapat V
    JACC Cardiovasc Interv; 2018 Sep; 11(17):1733-1743. PubMed ID: 30121280
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Final 3-Year Outcomes of a Randomized Trial Comparing a Self-Expanding to a Balloon-Expandable Transcatheter Aortic Valve.
    Lanz J; Möllmann H; Kim WK; Burgdorf C; Linke A; Redwood S; Hilker M; Joner M; Thiele H; Conzelmann L; Conradi L; Kerber S; Thilo C; Toggweiler S; Prendergast B; Husser O; Stortecky S; Deckarm S; Künzi A; Heg D; Walther T; Windecker S; Pilgrim T;
    Circ Cardiovasc Interv; 2023 Jul; 16(7):e012873. PubMed ID: 37417229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Is Bioprosthetic Valve Fracture Beneficial for Patients with Larger Surgical Valves Undergoing Valve in Valve TAVR?
    Chhatriwalla AK; Saxon JT; Cohen DJ; Allen KB
    Curr Cardiol Rep; 2018 Aug; 20(10):95. PubMed ID: 30135999
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of structural valve deterioration of transcatheter aortic bioprosthetic balloon-expandable valves using the new European consensus definition.
    Eltchaninoff H; Durand E; Avinée G; Tron C; Litzler PY; Bauer F; Dacher JN; Werhlin C; Bouhzam N; Bettinger N; Candolfi P; Cribier A
    EuroIntervention; 2018 Jun; 14(3):e264-e271. PubMed ID: 29599103
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Transcatheter Aortic Bioprosthesis Durability: A Single-Center Experience.
    Moroni F; Ziviello F; Federico F; Di Stefano D; Beneduce A; Vella CS; Ancona F; Ingallina G; Ancona M; Ferri LA; Russo F; Bellini B; Agricola E; Chieffo A; Montorfano M
    Cardiovasc Revasc Med; 2022 Oct; 43():1-6. PubMed ID: 35690553
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transcatheter aortic valve replacement in low-risk patients: 2-year results from the LRT trial.
    Waksman R; Torguson R; Medranda GA; Shea C; Zhang C; Gordon P; Ehsan A; Wilson SR; Levitt R; Hahn C; Parikh P; Bilfinger T; Butzel D; Buchanan S; Hanna N; Buchbinder M; Asch F; Weissman G; Ben-Dor I; Shults C; Garcia-Garcia HM; Satler LF; Rogers T
    Am Heart J; 2021 Jul; 237():25-33. PubMed ID: 33713618
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long-term echocardiographic findings after TAVR: 5-year follow-up in 400 consecutive patients.
    Stolcova M; Meucci F; Moretti C; Chiriatti N; Marcelli C; Mattesini A; Taglieri N; Ristalli F; Galiè N; Palmerini T; Di Mario C; Saia F
    Intern Emerg Med; 2021 Oct; 16(7):1873-1882. PubMed ID: 33770370
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.